ClearCyte believes that the true power of cancer screening can only be achieved when made affordable, easy and effective. Cancer screening is most valuable at its point of maximum impact: early.
The incidence of cancer is low enough that most patients and providers have a low index of suspicion, frequently leading to a wait and see approach. This arises from the large gap in care strategies between doing nothing and invasive procedures that provide confirmation of disease.
ClearCyte offers cytology based cancer screening which preserves the ability to perform molecular and genetic testing on the same sample, offering a ‘co-testing’ strategy that becomes more effective and specific with each passing cancer discovery.
CANCER SCREENING TECHNOLOGIES
With advances in cancer treatments based upon molecular and genetic testing, early detection has never been more important. No current diagnostic company offers an affordable, point-of-care, one sample cytology screening solution designed with molecular and genetic co-testing in mind.
Learn more about liquid-based cytology and how it relates to ClearCyte.
INNOVATIVE TECHNOLOGIES PROVIDING EASY-TO-USE, LOW-COST SOLUTIONS TO CANCER SCREENING.
OralCyte™ is an oral mucosa cancer screening solution. It is an off-the-shelf, single use all inclusive testing kit tailored to the primary care physician market. Utilizing a non-invasive swab biopsy collection method and patented collection vial, primary care physicians can quickly, painlessly and affordably screen any abnormalities with 99.7% accuracy.
MammoCyte™ is a breast cancer screening solution. It is tailored to the medical market for needle aspiration fluids and solid FNA specimens utilizing the patented collection vial and proprietary preservative and reagent solution. This test has consistently provided the cytopathologist with sufficient cells per high powered field to prove diagnostic utility. It is an off-the-shelf, single use all inclusive test.
UrClear™ is a bladder cancer screening solution for urologists and primary care physicians. The technology allows for ample cell concentration and preservation to obtain clinically viable analysis of a standard urine sample for detection of cancerous cell presence. UrClear is an off-the-shelf, easy-to-use, single use, all inclusive test.